Menopausal Hormone Therapy and Long-term All-Cause and Cause-Specific Mortality


This observational follow-up (cumulative 18 years) of postmenopausal women enrolled in 2 RCTs compared rates of all-cause, cardiovascular, and cancer mortality between groups receiving hormone therapy (conjugated equine estrogens [CEE] plus medroxyprogesterone acetate) or CEE alone vs placebo.